(2024) Evaluation of the effect of CYP2D6*3, *4,*10, and *17 polymorphisms on the pharmacokinetic of tamoxifen and its metabolites in patients with hormone-positive breast cancer. Journal of pharmaceutical and biomedical analysis. p. 115839. ISSN 1873-264X (Electronic) 0731-7085 (Linking)

(2024) Hydrogen Sulfide: Physiological Roles and Therapeutic Implications against COVID-19. Current Medicinal Chemistry. pp. 3132-3148. ISSN 0929-8673

(2024) Therapeutic Role of HAT Therapy in Sepsis: A Systematic Review and Meta-Analysis. Current medicinal chemistry. p. 25. ISSN 0929-8673

(2024) The role of natural products as PCSK9 modulators: A review. Phytotherapy Research. pp. 4081-4098. ISSN 0951418X (ISSN)

(2023) Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial. International Immunopharmacology.

(2023) The Potential of Cannabidiol for Acute Respiratory Distress Syndrome in COVID-19. Current pharmaceutical design. pp. 2291-2296. ISSN 1381-6128

(2023) An introduction to the pathophysiology of parasitic infection. In: Advances in Antiparasitic Therapies and Drug Delivery. Elsevier, pp. 1-32. ISBN 9780443151781 (ISBN); 9780443151798 (ISBN)

(2022) Cellular and Molecular Aspects of Managing Familial Hypercholesterole-mia: Recent and Emerging Therapeutic Approaches. Endocrine, Metabolic and Immune Disorders - Drug Targets. pp. 1018-1028.

(2022) Cellular and Molecular Aspects of Managing Familial Hypercholesterolemia: Recent and Emerging Therapeutic Approaches. Endocrine Metabolic & Immune Disorders-Drug Targets. pp. 1018-1028. ISSN 1871-5303

(2021) CD47 in the brain and neurodegeneration: An update on the role in neuroinflammatory pathways. Molecules.

(2021) Effect of atorvastatin on delirium status of patients in the intensive care unit: A randomized controlled trial. Archives of Medical Science. p. 1423.